NCT06813820View on ClinicalTrials.gov

RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial

NANot yet recruitingINTERVENTIONAL

Enrollment

135

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

August 31, 2028

Study Completion Date

August 31, 2032

Conditions

Left Ventricle RemodelingLeft Ventricle DilatedCHF

Interventions

DEVICE

Revivent System

BioVentrix has developed the Revivent System to mirror SVR. The Revivent System is used to place permanent cardiac implants to the epicardial surface for the purpose of reconfiguring abnormal cardiac geometry that is contributing to the dysfunction.